Visual Assessment Versus Quantitative Assessment of 11C-PIB PET and 18F-FDG PET for Detection of Alzheimer's Disease
Steven Ng1,
Victor L. Villemagne13,,
Sam Berlangieri1,
Sze-Ting Lee1,
Martin Cherk1,
Sylvia J. Gong1,
Uwe Ackermann1,
Tim Saunder1,
Henri Tochon-Danguy1,
Gareth Jones1,
Clare Smith1,
Graeme O'Keefe1,
Colin L. Masters2,3 and
Christopher C. Rowe1
1 Department of Nuclear Medicine, Centre for PET, Austin Health, Heidelberg, Victoria, Australia; 2 Department of Pathology, University of Melbourne, Parkville, Victoria, Australia; and 3 The Mental Health Research Institute of Victoria, Parkville, Victoria, Australia

View larger version (46K):
[in this window]
[in a new window]
|
FIGURE 1. 11C-PIB PET images show white matter uptake of 11C-PIB in HC subject (top) and extensive cortical and subcortical uptake in AD patient (bottom). Note relative sparing of sensorimotor and occipital cortex in AD patient.
|
|

View larger version (59K):
[in this window]
[in a new window]
|
FIGURE 2. SPM analysis of AD vs. HC subjects. Results are superimposed on transverse T1-weighted MRI brain templates at level of caudate nucleus (left) and at level of posterior cingulate cortex (right). Highlighted areas represent brain regions where AD had significantly higher 11C-PIB uptake than HC. Five regions (indicated by arrows) are clearly identified (height threshold, uncorrected P = 0.01; voxel extension, 125).
|
|

View larger version (6K):
[in this window]
[in a new window]
|
FIGURE 3. Box plot of 11C-PIB mrDVR of HC and AD shows median value, quartiles, outliers (*), and mean ( ). Mean mrDVR (HC) = 1.19 ± 0.17 vs. mean mrDVR (AD) = 2.02 ± 0.23 (P < 0.01; Cohen's effect size = 3.87 indicates nonoverlap of 97% in 2 distributions).
|
|

View larger version (7K):
[in this window]
[in a new window]
|
FIGURE 4. Box plot of 18F-FDG mrSUVR of HC and AD shows median value, quartiles, outliers (*), and mean ( ). Mean mrSUVR (HC) = 1.10 ± 0.09 vs. mean mrSUVR (AD) = 0.91 ± 0.15 (P < 0.01; Cohen's effect size = 1.53 indicates nonoverlap of 71% in 2 distributions).
|
|
Copyright © 2007 by the Society of Nuclear Medicine.